Infections, Clostridium Difficile Clinical Trial
Official title:
A Serological Study in Adult Subjects With Clostridium Difficile Infection
This study aims to 1) evaluate the C. difficile-specific immune response in CDI patients and 2) explore the difference in immune response between the patients with CDI recurrence and those with a sustained clinical response.
Patients with an initial episode of CDI will be followed up for CDI recurrence or sustained
clinical response. The subjects will be allocated into 2 groups at the study end:
- Recurrence Group: Subjects who experience recurrence of CDI after clinical response to
antibiotic treatment to treat the initial CDI episode.
- Sustained response Group: Subjects who do not experience recurrence of CDI after
clinical response to the antibiotic treatment to treat the initial CDI episode.
This protocol has been amended twice to improve recruitment of subjects in the study.
;